ANGO
AngioDynamics, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$15.05
−2.75%Year over year
Reported trailing growth
- Revenue
- +9.5%
- EBITDA
- —
- EBIT
- +0.1%
- EPS
- -6.0%
- Free cash flow
- +103.5%
- Operating cash flow
- +130.5%
Forward estimates
Based on analyst estimates
- Revenue
- -19.8%
- EBITDA
- +84.8%
- EPS
- +82.9%
Three-year CAGR
- Revenue
- -1.9%
- EBITDA
- -75.1%
- EBIT
- +0.1%
- Net income
- -8.1%
- EPS
- -6.0%
- Free cash flow
- +103.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of May 1, 2026